The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 165.80
Bid: 165.60
Ask: 166.00
Change: 1.00 (0.61%)
Spread: 0.40 (0.242%)
Open: 166.00
High: 167.80
Low: 164.00
Prev. Close: 164.80
CCR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - C&C Group PLC

10 Dec 2014 13:19

RNS Number : 4029Z
BlackRock Group
10 December 2014
 



FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

BlackRock, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

C&C Group PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

09 December 2014

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

Yes, Spirit Pub Company PLC, Greene King PLC

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

1 EUR Cent ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

5,218,849

1.50%

0

0.00%

(2) Derivatives (other than options):

1,285,561

0.36%

2,511,284

0.72%

(3) Options and agreements to purchase/sell:

0

0.00%

0

0.00%

TOTAL:

6,504,410

1.86%

2,511,284

0.72%

 

The change in the holding of 2,358 shares since the last disclosure for 8th December is due to the transfer in of a discretionary holding.

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase

or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1©, copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

1 EUR Cent ordinary

Sale

6,506

EUR 3.5630

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

1 EUR Cent ordinary

CFD

Increasing Long

22,774

EUR 3.5630

1 EUR Cent ordinary

CFD

Increasing Long

14,966

EUR 3.5645

1 EUR Cent ordinary

CFD

Increasing Long

1,184

EUR 3.5670

1 EUR Cent ordinary

CFD

Increasing Long

8,966

EUR 3.5966

1 EUR Cent ordinary

CFD

Increasing Short

11,764

EUR 3.5678

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

None.

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None.

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

Date of disclosure:

10 December 2014

Contact name:

Gareth Slade

Telephone number:

+44 20 7743 2536

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETEADAEFFXLFFF
Date   Source Headline
5th Dec 20224:30 pmRNSHolding(s) in Company
2nd Dec 20222:28 pmRNSDirector Declaration
30th Nov 20224:45 pmRNSTotal Voting Rights
30th Nov 20227:00 amRNSBlock listing Interim Review
21st Nov 202212:00 pmRNSDirector/PDMR Shareholding
18th Nov 20227:10 amRNSDirector Declaration
9th Nov 20229:15 amRNSHolding(s) in Company
14th Sep 20227:00 amBUSStatement re H1 pre-close Trading Statement
16th Aug 20222:15 pmRNSDirector/PDMR Shareholding
28th Jul 202211:00 amRNS2021 Long Term Incentive Plan (‘LTIP’) Awards
26th Jul 20223:15 pmRNSDirector/PDMR Shareholding
20th Jul 202212:00 pmRNSDirector/PDMR Shareholding
18th Jul 20224:00 pmRNSHolding(s) in Company
15th Jul 20225:05 pmRNSDirector/PDMR Shareholding
7th Jul 20222:30 pmRNSResult of AGM
7th Jul 20227:00 amBUSAGM Statement
29th Jun 20223:30 pmRNSHolding(s) in Company
23rd Jun 20225:39 pmRNSHolding(s) in Company
15th Jun 20225:10 pmRNSDirector/PDMR Shareholding
10th Jun 20227:00 amRNSDirector/PDMR Shareholding
8th Jun 20228:30 amRNSAnnual Report and Notice of AGM
31st May 20224:45 pmRNSHolding(s) in Company
31st May 20227:00 amRNSBlock listing Interim Review
30th May 202210:00 amRNSHolding(s) in Company
24th May 20225:45 pmRNSHolding(s) in Company
17th May 20222:00 pmRNSDirector/PDMR Shareholding
17th May 20227:00 amBUSFinal Results
3rd May 20224:15 pmRNSDirector/PDMR Shareholding
16th Mar 20222:30 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amBUSTrading Statement
16th Feb 20223:45 pmRNSDirector/PDMR Shareholding
15th Feb 20222:45 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Jan 20227:00 amBUSTrading Statement
20th Dec 20213:00 pmRNSDirector/PDMR Shareholding
15th Dec 20217:00 amBUSStatement re Notice of Capital Markets Day
3rd Dec 20219:35 amRNSHolding(s) in Company
1st Dec 202110:45 amRNSDirector Declaration
30th Nov 20217:00 amRNSBlock listing Interim Review
17th Nov 202111:45 amRNSDirector/PDMR Shareholding
29th Oct 20213:47 pmRNSHolding(s) in Company
28th Oct 20217:00 amBUSHalf-year Report
19th Oct 20215:00 pmRNSDirector/PDMR Shareholding
12th Oct 20215:15 pmRNSHolding(s) in Company
20th Sep 20214:00 pmRNSHolding(s) in Company
17th Sep 20216:00 pmRNSHolding(s) in Company
16th Sep 20212:25 pmBUSStatement re Chairman Appointment
16th Sep 20217:00 amBUSTrading Statement
15th Sep 20215:50 pmRNSDirector/PDMR Shareholding
15th Sep 20214:08 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.